“ Inflammation as a Modifiable Driver of Ischemic Heart Disease: Mechanisms, Clinical Risks, and Evolving Therapeutic Options” (2025) Journal of Carcinogenesis, 24(10s), pp. 488–501. doi:10.64149/J.Carcinog.24.10s.488-501.